company background image
PYFA logo

Pyridam Farma IDX:PYFA Stock Report

Last Price


Market Cap







21 Jun, 2024


Company Financials

PYFA Stock Overview

Engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.

PYFA fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health1/6

PT Pyridam Farma Tbk Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pyridam Farma
Historical stock prices
Current Share PriceRp107.00
52 Week HighRp1,545.00
52 Week LowRp81.00
11 Month Change-13.01%
3 Month Change-86.87%
1 Year Change-87.03%
33 Year Change-88.91%
5 Year Change-43.09%
Change since IPO-61.79%

Recent News & Updates

Recent updates

Shareholder Returns

PYFAID PharmaceuticalsID Market

Return vs Industry: PYFA underperformed the ID Pharmaceuticals industry which returned -22.5% over the past year.

Return vs Market: PYFA underperformed the ID Market which returned 0.5% over the past year.

Price Volatility

Is PYFA's price volatile compared to industry and market?
PYFA volatility
PYFA Average Weekly Movement30.0%
Pharmaceuticals Industry Average Movement7.3%
Market Average Movement5.8%
10% most volatile stocks in ID Market12.9%
10% least volatile stocks in ID Market2.6%

Stable Share Price: PYFA's share price has been volatile over the past 3 months.

Volatility Over Time: PYFA's weekly volatility has increased from 17% to 30% over the past year.

About the Company

19761,193Yan Gwan

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates in two segments, Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR – extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper.

PT Pyridam Farma Tbk Fundamentals Summary

How do Pyridam Farma's earnings and revenue compare to its market cap?
PYFA fundamental statistics
Market capRp1.24t
Earnings (TTM)-Rp85.22b
Revenue (TTM)Rp702.07b


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PYFA income statement (TTM)
Cost of RevenueRp406.75b
Gross ProfitRp295.32b
Other ExpensesRp380.54b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date


Earnings per share (EPS)-7.58
Gross Margin42.06%
Net Profit Margin-12.14%
Debt/Equity Ratio273.3%

How did PYFA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.